BDBM350643 US10208071, Compound 105::US10434112, Compound 105::US10799518, Compound 105::ethyl hydrogen ({[(2S)-2-{[(4- bromophenyl)carbamoyl]amino}- 4-methylpentanoyl]amino} methyl)phosphonate

SMILES CCOP(O)(=O)CNC(=O)[C@H](CC(C)C)NC(=O)Nc1ccc(Br)cc1

InChI Key InChIKey=VFLQQXWSIKNIQK-UHFFFAOYSA-N

Data  3 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 350643   

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350643(ethyl hydrogen ({[(2S)-2-{[(4- bromophenyl)carbamo...)
Affinity DataEC50:  0.950nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/16/2020
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350643(ethyl hydrogen ({[(2S)-2-{[(4- bromophenyl)carbamo...)
Affinity DataEC50:  0.950nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/1/2021
Entry Details
US Patent

TargetN-formyl peptide receptor 2(Human)
Allergan

US Patent
LigandPNGBDBM350643(ethyl hydrogen ({[(2S)-2-{[(4- bromophenyl)carbamo...)
Affinity DataEC50:  950nMAssay Description:HEK-Gα16 cells stably expressing the human FPR2 receptor was utilized. Cells were plated into 384-well poly-D-lysine coated plates at a density ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/21/2019
Entry Details
US Patent